Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical Endocrinology

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2265.1997.2361058.xPMID 9373449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction.

  1997cited by this paper
• Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

  1996cited by this paper
• Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.

  1996cited by this paper
• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

  1996cited by this paper
• Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.

  1995cited by this paper
• Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators.

  1995cited by this paper
• Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.

  1995cited by this paper
• The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.

  1995influential reference
• Plasma brain natriuretic peptide in assessment of acute dyspnoea.

  1994cited by this paper
• N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

  1994cited by this paper
• Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

  1994cited by this paper
• Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.

  1994cited by this paper
• Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men.

  1994cited by this paper
• Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

  1994cited by this paper
• The plasma concentration of N‐terminal proatrial natriuretic factor anf (1‐98) is related to prognosis in severe heart failure

  1994cited by this paper
• Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

  1993cited by this paper
• Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction

  1993cited by this paper
• Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.

  1993cited by this paper
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

  1993cited by this paper
• Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

  1993cited by this paper
• Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.

  1993cited by this paper
• Receptors of atrial natriuretic factor.

  1992cited by this paper
• Concentrations and molecular forms of human brain natriuretic peptide in plasma.

  1992cited by this paper
• Expression of Brain Natriuretic Peptide Gene in Human Heart: Production in the Ventricle

  1991cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid.

  1991cited by this paper
• Augmented secretion of brain natriuretic peptide in acute myocardial infarction.

  1991cited by this paper
• Isolation and identification of human brain natriuretic peptides in cardiac atrium.

  1990cited by this paper
• Isolation and sequence determination of human brain natriuretic peptide in human atrium

  1990cited by this paper
• Contribution of the kidney to metabolic clearance of atrial natriuretic peptide.

  1988cited by this paper
• Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor).

  1988cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life.

  1988cited by this paper
• Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

  1988cited by this paper
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

  1987cited by this paper
• Haemodynamic effects of atrial peptide infusion in heart failure.

  1986cited by this paper
• Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma.

  1986cited by this paper
• Incorrect least-squares regression coefficients in method-comparison analysis.

  1979cited by this paper

• Effect of Compound Danshen Dripping Pills on cardiac function after acute anterior ST-segment elevation myocardial infarction: A randomized trial

  2025cites this paper
• Prognostic impact of excessive mitochondrial fission in patients with heart failure and evaluation of mitochondrial dynamics-related miRNAs in heart failure

  2025cites this paper
• Prognostic significance of the preoperative level of biomarker NT-proBNP in myocardial revascularization with cardiopulmonary bypass (pilot study)

  2025cites this paper
• Clinical Significance of NT-proBNP in Patients with Low BNP Requiring Non-Surgical Intensive Care.

  2025cites this paper
• NT-proBNP and BNP as Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis

  2025cites this paper
• Clinical significance of mitochondrial dynamics-related miRNAs in the superacute phase of acute heart failure in patients presenting to the emergency department.

  2025cites this paper
• When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis

  2024cites this paper
• Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD

  2024cites this paper
• Sizing and mending of appendicular muscle mass for hydration during the 12‐lead electrocardiogram: True incidence of sarcopenia in heart failure

  2024cites this paper
• NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease

  2024cites this paper
• Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry—A Cardiac Magnetic Resonance Imaging Study

  2024cites this paper
• Relationship between N-terminal pro-brain natriuretic peptide concentration and heart-type fatty acid-binding protein in postmortem urine.

  2024cites this paper
• Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction

  2023cites this paper
• BNP and NT-proBNP Thresholds for the Assessment of Prognosis in Patients Without Heart Failure

  2023cites this paper
• Risk prediction of atrial fibrillation and its complications in the community using hs troponin I

  2023cites this paper
• EMMY: The continued expansion of clinical applications of SGLT2 inhibitors

  2023cites this paper
• The Predictive Value of A, B, and C-Type Natriuretic Peptides in People at Risk of Heart Disease: Protocol for a Longitudinal Observational Study

  2023cites this paper
• Assays Specific for BNP1-32 and NT-proBNP Exhibit a Similar Performance to Two Widely Used Assays in the Diagnosis of Heart Failure.

  2022cites this paper
• Comparison of Mortality Prediction by the GRACE Score, Multiple Biomarkers, and Their Combination in All-comer Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2022cites this paper
• Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis

  2022cites this paper
• A New Hematocrit Measurement Method Using a Chemiluminescence Biosensor and Its Application in a Chemiluminescence Immunoassay Platform for Myocardial Markers Detection with Whole Blood Samples

  2022cites this paper
• Prognostic Value of Admission Peak NT-proBNP Combined with Culprit Plaque Types for Predicting Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study

  2022cites this paper
• Biomarker Development in Cardiology: Reviewing the Past to Inform the Future

  2022cites this paper
• Harnessing nanotechnology for cardiovascular disease applications - a comprehensive review based on bibliometric analysis

  2022cites this paper
• Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.

  2021cites this paper
• β1-adrenergic and Muscarinic Acetylcholine Type 2 Receptor Antibodies are Increased in Graves' Hyperthyroidism and Decrease During Antithyroid Therapy.

  2021cites this paper
• BNP and NT-proBNP concentrations in paired cerebrospinal fluid and plasma samples of patients with traumatic brain injury.

  2021cites this paper
• Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China

  2021cites this paper
• Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain

  2021cites this paper
• The Relationship Between N-Terminal Pro-Brain Natriuretic Peptide Level and Myocardial Performance Index and Their Prognostic Importances in Patients With Acute Myocardial Infarction in Short Term Follow-up

  2020cites this paper
• Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points.

  2020cites this paper
• Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis

  2020cites this paper
• Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?

  2020cites this paper
• Postmortem urine concentration of N-terminal pro-brain natriuretic peptide in relation to the cause of death.

  2019cites this paper
• Biomarkers in the Diagnosis, Management, and Prognostication of Perioperative Right Ventricular Failure in Cardiac Surgery—Are We There Yet?

  2019cites this paper
• ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased With Obesity in Patients with Heart Failure.

  2019cites this paper
• Perioperative Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide (NT- proBNP) Level in Patients Undergoing Open Heart Surgery

  2019cites this paper
• Predictive values of dyslipidemia and B-type natriuretic peptide levels in juvenile systemic lupus erythematosus: A two center-experience

  2019cites this paper
• Electrolyte/Renal abnormalities cardiomyopathy: A review and pooled analysis of pathophysiology, diagnosis and clinical management

  2019cites this paper
• Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging

  2019cites this paper
• Simultaneous colorimetric determination of acute myocardial infarction biomarkers by integrating self-assembled 3D gold nanovesicles into a multiple immunosorbent assay

  2019cites this paper
• Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans

  2019cites this paper
• Diagnosing cardiovascular disease in western lowland gorillas (Gorilla gorilla gorilla) with brain natriuretic peptide

  2019cites this paper
• The Predictivity of N-Terminal Pro b-Type Natriuretic Peptide for All-Cause Mortality in Various Follow-Up Periods among Heart Failure Patients

  2019cites this paper
• Circulatory factors associated with function and prognosis in patients with severe heart failure

  2019cites this paper
• Characterisation of N-terminal pro-brain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly

  2019cites this paper
• N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients

  2018cites this paper
• Evaluation of the Prognostic Value of BNP in Prediction of Sudden Cardiac Death in Patients with Left Ventricular Dysfunction after an Acute MI

  2018cites this paper
• Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial

  2018cites this paper
• Utility of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) in the postmortem diagnosis of ischemic heart disease.

  2018cites this paper
• Influence of Serum Biomarkers in the Diagnostic , Prognostic and Therapeutic Management of Patients with Heart Failure

  2018cites this paper
• 12. RATIONAL DIAGNOSIS OF CARDIOVASCULAR DISEASE

  2018cites this paper
• Exosomal microRNA-29a mediates cardiac dysfunction and mitochondrial inactivity in obesity-related cardiomyopathy

  2018cites this paper
• Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP

  2018cites this paper
• Relationship between Perioperative N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Complications in Thoracic Surgery

  2018cites this paper
• Exosomal microRNA-194 causes cardiac injury and mitochondrial dysfunction in obese mice.

  2018cites this paper
• N-Terminal B-type Natriuretic Peptide in Heart Failure.

  2018cites this paper
• Natriuretic Peptides and Normal Body Fluid Regulation.

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• New Insights into Cardiac and Vascular Natriuretic Peptides: Findings from Young Adults Born with Very Low Birth Weight.

  2018cites this paper
• Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy

  2018cites this paper
• Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study

  2018cites this paper
• What Is High Enough? Elevated NT-pro-BNP in Decompensated Paroxysmal Supraventricular Tachycardia

  2017cites this paper
• Effects of oxygen therapy on wall‐motion score index in patients with ST elevation myocardial infarction—the randomized SOCCER trial

  2017cites this paper
• The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure.

  2017cites this paper
• Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP.

  2017cites this paper
• YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.

  2017cites this paper
• N‐terminal pro‐brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic

  2017cites this paper
• Prognostic impact of intensive statin therapy on N‐terminal pro‐BNP level in non‐ST‐segment elevation acute myocardial infarction patients

  2017cites this paper
• Cardiac Natriuretic Peptides

  2017cites this paper
• Value of serum N-terminal B-type natriuretic peptide in asymptomatic structural heart disease in Taiwanese population: Comparisons with current ESC Guidelines.

  2017cites this paper
• A novel strategy for rapid detection of NT-proBNP

  2017cites this paper
• Association between increased N-terminal pro-brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke.

  2017cites this paper
• Elecsys proBNP II

  2017cites this paper
• A New Method for Blood NT-proBNP Determination Based on a Near-infrared Point of Care Testing Device with High Sensitivity and Wide Scope.

  2017cites this paper
• Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.

  2017cites this paper
• P mino-Terminal ProB-Type atriuretic Peptide and B-Type atriuretic Peptide in the General Community eterminants and Detection of Left Ventricular Dysfunction

  2016cites this paper
• The Endocrine Heart

  2016cites this paper
• Pathophysiology of Heart Failure and an Overview of Therapies

  2016cites this paper
• Highly sensitive detection of NT-proBNP by molecular motor

  2016cites this paper
• Carcinoid heart disease : biochemical and echocardiographic assessment

  2016cites this paper
• Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide

  2016cites this paper
• Acute Myocardial Infarction Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction

  2016cites this paper
• Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease

  2016cites this paper
• Dyslipidemia in patients with systemic lupus erythematosus: Association with disease activity and B-type natriuretic peptide levels.

  2016cites this paper
• Release of Cardiac Biomarkers during a Cycling Race

  2016cites this paper
• Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.

  2016cites this paper
• Vitamin D Deficiency Contributes to the Reduction and Impaired Function of Naïve CD45RA+ Regulatory T Cell in Chronic Heart Failure

  2015cites this paper
• Urinary NT-proBNP is Independently Associated with Long-term Prognosis of Mortality in Chronic Heart Failure

  2015cites this paper
• Clinical value of natriuretic peptides in chronic kidney disease.

  2015cites this paper
• Clinical value of plasma B-type natriuretic peptide assay in pediatric pneumonia accompanied by heart failure.

  2015cites this paper
• Vitamin D Deficiency Contributes to the Reduction and Impaired Function of Na \ ve CD 45 RA + Regulatory T Cell in Chronic Heart Failure

  2015cites this paper
• Fibroblast-specific protein-1(FSP-1) expression and metabolic alteration in aortic valve calcification

  2015cites this paper
• B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.

  2015cites this paper
• Diagnóstico precoz de la enfermedad cardiovascular en el lupus eritematoso sistémico

  2015cites this paper
• Novel biomarkers for risk stratification of acute coronary syndromes.

  2015cites this paper
• Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs.

  2014cites this paper
• Breed Differences in Natriuretic Peptides in Healthy Dogs

  2014cites this paper
• Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure.

  2014cites this paper
• A silicon nanowire-based bio-sensing system with digitized outputs for acute myocardial infraction diagnosis

  2014cites this paper